Consuming too much salt has long been recognized as a primary catalyst for hypertension and cardiovascular distress. However, a growing body of scientific inquiry suggests that the consequences of an excessive sodium diet extend far beyond blood pressure, quietly compromising memory, cognitive flexibility, and emotional well-being. As public health officials grapple with the widespread prevalence of high-sodium diets, finding novel therapeutic or dietary interventions to mitigate salt-induced neurological and vascular damage has become an urgent priority in medical research.
In a significant step forward, a research team in Japan has identified a promising therapeutic candidate in LPC70, a specialized compound derived from soybeans. Building on previous investigations that demonstrated the ingredient’s capacity to alleviate high blood pressure and cognitive deficits in mice subjected to a high-salt diet, a team of scientists has taken a much closer look at the underlying biological mechanisms. Their latest findings reveal that the compound exerts a profound influence on critical chemical signaling pathways located in both the kidneys and the brain, offering a clearer picture of how nutritional science might one day protect vulnerable populations from the systemic damage caused by excessive salt.
How a Soy Compound May Counter the Effects of Excess Salt
At the heart of the new research are prostaglandins, a diverse group of physiological signaling molecules synthesized from arachidonic acid, a vital fatty acid. These substances function much like local hormones, exerting precise regulatory control over essential physiological functions throughout the human body. In the cardiovascular system, prostaglandins play an indispensable role in maintaining vascular tone, carefully balancing the widening and narrowing of blood vessels to help regulate blood pressure.
Their operational landscape within the central nervous system, however, is substantially more complex. Depending on which specific receptors they bind to and activate, prostaglandins can trigger biochemical signals that either shield nerve cells from injury or accelerate harmful inflammatory processes. These downstream effects have the potential to directly influence memory retention, higher-order thinking, and emotional regulation.
LPC70 itself is a specialized form of soy lysolecithin, characterized by lysophosphatidylcholine accounting for more than 70 percent of its total phospholipid content. Although earlier experiments confirmed that this soybean derivative could successfully ease salt-related hypertension and cognitive difficulties in experimental models, the precise molecular mechanisms responsible for these benefits remained poorly understood, particularly regarding its interactions with prostaglandin signaling pathways.
To bridge this knowledge gap, a collaborative research team led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close partnership with Dr. Kazuhiro Kagotani, set out to examine how LPC70 alters these vital pathways in mice maintained on a high-salt diet. Dr. Kubota, who served as the study’s first author, was instrumental in executing the laboratory experiments. He systematically evaluated blood pressure metrics, observed nuanced behavioral changes, and analyzed the molecular activity tied to prostaglandins, clarifying how LPC70 manages to produce distinct, organ-specific effects in the vital systems most vulnerable to sodium overload.
Prof. Mouri and Dr. Kubota conduct their academic and scientific work within the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, alongside their affiliations with the International Center for Brain Science at Fujita Health University in Japan. Meanwhile, Dr. Kagotani brings an industry and applied research perspective, maintaining appointments at Tsuji Oil Mills Co., Ltd. in Japan and the Tsuji Health and Beauty Science Laboratory at Mie University.
The comprehensive findings from their collaborative effort were released online on May 14, 2026, and subsequently published in Volume 197 of the peer-reviewed journal Neurochemistry International on July 1, 2026. Discussing the origins of the project, Prof. Mouri noted that the investigation stemmed from a joint initiative with Tsuji Oil Mills Co., Ltd., a company specializing in the development of naturally derived food ingredients. The primary goal, according to the researchers, was to understand the precise role LPC70 plays in orchestrating shifts in prostaglandin signaling across multiple organ systems simultaneously.
Soy Compound Improves Blood Pressure and Memory in Mice
As anticipated by the research team, mice subjected to a high-salt diet rapidly developed elevated blood pressure levels, confirming the baseline effectiveness of the dietary intervention. However, the negative consequences of the sodium-rich regimen extended far beyond their cardiovascular profiles. Behavioral evaluations revealed that the animals also experienced notable drops in social interaction and struggled significantly with object recognition memory—failing to properly identify items they had encountered during prior testing sessions.
Interestingly, the mice did not exhibit broad behavioral disruptions; their general locomotor activity and anxiety-like behaviors remained largely unchanged. This specific pattern of behavioral alteration strongly indicates that excessive salt consumption selectively disrupts complex cognitive and social functions rather than causing generalized, system-wide impairment across all behavioral domains.
When the researchers introduced LPC70 as a dietary supplement to the high-salt group, a remarkable reversal of these negative outcomes occurred. The animals experienced measurable improvements in blood pressure regulation, alongside a distinct recovery in their performance during tests measuring social interaction and recognition memory. These encouraging behavioral and physiological shifts prompted the scientific team to look deeper into the biological machinery operating within the tissues of the test subjects.
Different Protective Effects in the Kidneys and Brain
To understand how the soy compound achieved these protective benefits, the researchers analyzed tissue samples from both the kidneys and the brain, uncovering distinct mechanisms of action in each organ system. In the kidneys, a high-salt diet significantly increased the expression of two key molecular components involved in prostaglandin signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these proteins are heavily implicated in driving the pathological elevation of blood pressure associated with excessive dietary sodium.
When LPC70 was administered, it successfully suppressed these salt-induced elevations. This indicated that the compound helps correct dysregulated kidney signaling pathways that would otherwise interfere with the body’s natural capacity to maintain healthy blood pressure limits.
In the prefrontal cortex—a brain region critical for higher-order thinking, executive function, working memory, and social behavior—the researchers observed a completely different physiological response. Excess salt consumption led to a marked reduction in the expression of the PGD2 receptor DP1, a protein heavily involved in neuroprotective and anti-inflammatory signaling within the central nervous system. Notably, LPC70 treatment successfully restored the expression of this protective receptor without altering DP2, a separate receptor subtype that is frequently associated with neurotoxic or otherwise harmful effects on nerve cells.
This nuanced distinction is vital to understanding the therapeutic potential of the compound. It demonstrates that LPC70 does not operate as a blunt instrument that merely increases or suppresses all prostaglandin activity indiscriminately. Instead, it selectively favors biochemical pathways that promote neuroprotection and vascular stability, offering a plausible explanation for the restored memory function and social behaviors observed in the treated mice.
A Surprising Change in Chemical Signaling
Beyond mapping receptor expression, the research team uncovered an unexpected biochemical shift involving arachidonic acid, the foundational fatty acid the human body relies on to manufacture prostaglandins in the first place. Mice subjected to a heavy salt burden displayed noticeably lower circulating levels of arachidonic acid in their systems. Yet, when these same animals received the LPC70 supplement, the actual tissue concentrations of downstream prostaglandins derived from that fatty acid—including PGE2 and PGD2—actually increased.
This seemingly contradictory result points to a sophisticated metabolic mechanism. The data suggests that LPC70 may optimize the body’s biochemical efficiency, enabling it to make better use of available arachidonic acid stores to synthesize protective prostaglandins even under the metabolic stress of a high-salt diet.
Taken as a whole, these findings highlight a remarkably coordinated yet highly selective physiological response. In the renal system, the compound works to counteract signaling shifts that drive hypertension, while in the cerebral cortex, it restores pathways dedicated to inflammation defense and neural preservation. Consequently, the ultimate impact of the soy-derived ingredient depends heavily on both the targeted organ and the specific prostaglandin receptor profiles being managed.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
While the current findings are derived entirely from animal models, they lay a compelling foundation for the future development of functional food ingredients designed to buffer the human body against the chronic toll of high sodium intake. The ability of LPC70 to simultaneously ameliorate hypertension and protect cognitive performance in mice raises exciting possibilities for supporting long-term cardiovascular and neurological health in human populations where sodium-heavy diets remain a persistent dietary challenge.
Nevertheless, the researchers emphasize that translating these animal findings into effective human treatments will require extensive clinical trials and human dietary studies. As Prof. Mouri noted in concluding the study, the research successfully illuminates the precise role of LPC70 in coordinating prostaglandin signaling, establishing the groundwork necessary for future clinical investigations and targeted nutritional interventions designed to combat hypertension-related cognitive decline and support healthy aging on a global scale.
The study received financial backing and operational support through a series of prestigious grants and institutional programs. These include Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, alongside contributions from the Fujita Mind-Brain Research and Innovation Center for Drug Generation through Japan’s Peak Research Universities Program, and the Japan Science and Technology Agency FOREST Program. Additional funding and research resources were supplied by Tsuji Oil Mills Co., Ltd., the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.
